Resistant Starch (RS2)
“The Butyrate Builder.” A precision fibre we use to rebuild butyrate, strengthen the gut barrier, and improve metabolic signalling.
The Naturopathic Perspective
“The Microbiome Carbohydrate.”
From a naturopathic lens, resistant starch (RS) is less a “carb” and more a targeted fermentation substrate—a tool we use to feed specific gut microbes so they can produce short-chain fatty acids (SCFAs), especially butyrate. Butyrate matters because it supports colonocyte fuel needs, barrier integrity, and mucosal immune balance, which echoes outward into systemic inflammation and insulin sensitivity.
In practice, we think of RS as a missing ecological input: many patients are not deficient in calories—they’re deficient in fermentation. When we restore RS, the goal isn’t “more fibre” in a generic sense; it’s more of the right fermentation, in the right person, at the right pace.
💡 Clinical Insight: The Depletion Gap
Why not just food?
1. Processing Removes RS: Milling, refining, and “fresh-hot” starch habits reduce the intake of intact/retrograded starch; content is highly sensitive to processing and storage.
2. Modern Under-Fermentation: Antibiotics, low-fibre patterns, and dysbiosis can reduce butyrate-producers, so patients may need a deliberate, therapeutic reintroduction.
“We prescribe this to bridge the gap between biological necessity and modern depletion.”
Naturopathic Use Cases
How we use this in clinical practice, validated by evidence.
1. Metabolic Control (Prediabetes/T2D)
Clinical Goal: Glucose & Insulin Sensitivity
The Clinical Logic:
We use RS to reduce digestible starch exposure in the small intestine and increase colonic fermentation products (SCFAs). This influences insulin sensitivity, inflammation, incretin signalling, and hepatic glucose handling.
Mechanistically, it’s a “carb swap” that behaves like fibre while also changing downstream metabolic signalling.
Very High
Grade A
Verdict: Validated. Evidence consistently supports a lower post-meal blood glucose rise when RS replaces digestible starch. Broader outcomes show moderate improvements, especially in metabolically impaired groups.
2. Constipation & Regularity
Clinical Goal: Microbiota & Frequency
The Clinical Logic:
RS functions as a prebiotic starch that increases fermentation, helps shift gut ecology (often toward Bifidobacterium), and improves stool frequency and consistency via microbial metabolites and changes in colonic environment.
Ideal for the “Dry + Sluggish Gut” phenotype, often after antibiotics or low-fibre dieting.
Moderate
Grade B
Verdict: A placebo-controlled RCT in adults with chronic constipation found RS3 improved stool frequency and healthy stools versus placebo. Responses vary by baseline microbiome.
3. Colonic Ecology (Butyrate)
Clinical Goal: SCFA Production
The Clinical Logic:
RS escapes small intestinal digestion and is fermented in the colon, increasing total SCFAs and butyrate. Butyrate is a key metabolite linked to colonic health, supporting mucosal energy needs and influencing immune tone and barrier function.
Incontestable
Grade A
Verdict: Human RCT data show RS-containing diets usually increase fecal SCFAs including butyrate (with known inter-individual variability).
Form Matters: Quality Comparison
Why we prescribe RS2 (High-Amylose Maize) over other forms.
The “Hero” Form: RS2 (High-Amylose Maize)
Why superior: It is the most studied in clinical trials, generally neutral in taste, and often standardised (reliable grams of RS per serve), making dosing and outcomes more predictable.
Food Sources (Approximate)
Foods to include for a “food-first” foundation.
Red Kidney Beans
~4.85 g RS
(Per 150g Canned)
Brown Lentils
~3.24 g RS
(Per 150g Canned)
Chickpeas
~3.09 g RS
(Per 150g Canned)
Lebanese Bread
~0.92 g RS
(Per 40g Serve)
📚 Clinical References & Evidence
-
Butyrate/SCFA Production (Grade A):
McOrist et al. (2011). “Fecal butyrate levels vary widely among individuals but are usually increased by a diet high in resistant starch.” Journal of Nutrition.
[Read Source] -
Health Impact & Processing:
“Harnessing the power of resistant starch: a narrative review of its health impact and processing challenges.” PMC.
[Read Source] -
Tolerability in IBS:
“Evaluating tolerability of resistant starch 2, alone and in combination with minimally fermented fibre for patients with IBS.” PMC.
[Read Source] -
Regulatory Claim (EU):
“Commission Regulation (EU) No 432/2012… establishing a list of permitted health claims.” EUR-Lex.
[Read Source] -
Glycaemic Control (Meta-Analysis):
“Effects of resistant starch on glycaemic control: a systematic review and meta-analysis.” Cambridge University Press.
[Read Source] -
Chronic Constipation (RCT):
“Impact of resistant starch type 3 on fecal microbiota and stool frequency in Thai adults with chronic constipation.” PubMed.
[Read Source] -
Food Content Data:
Hareer et al. (2024). Measured RS in foods (Australia; AOAC-type approach).
*Disclaimer: Links connect to third-party scientific repositories. Access may require institutional login for some journals.
📋 Dosage & Safety Guidelines
15-30 g
Start low (5-15g) and increase gradually.
- Psyllium Husk: Helps stool bulk/tolerability.
- PHGG: Mixed-fibre strategy for sensitive guts.
- Titration: Slow increase reduces gas/bloating.
Unsure if this is right for you?
Supplements work best when tailored to your individual biochemistry.